IBD Infusion & Infusion Therapy Services

Your Gastrointestinal Health Infusion Center in EAU CLAIRE, WAUSAU, MADISON AND onalaska, WI

Gastrointestinal issues can have a significant impact on your overall health and wellbeing. These chronic conditions cause painful symptoms that can disrupt daily activities and make it difficult to stay physically active, as well as put you at risk for more serious complications.

At Smart Infusion, we specialize in providing infusion therapy services to help patients with gastrointestinal issues manage their symptoms and maximize quality of life. Our facility boasts a 3:1 nurse to patient ratio, as well as comfortable seating, WiFi, Hulu, and whatever snacks and beverages you need to stay hydrated and fed during your infusion.

If you're ready to receive your therapy in the most patient-focused infusion center available, the team at Smart Infusion is here to help you. Schedule an appointment for the best IV therapy Wisconsin has to offer today.

Request Appointment

Infusion Therapy For Patients With Inflammatory Bowel Disease

Infusion therapy can help patients with a range of GI concerns, including the following.

Crohn’s Disease

Crohn’s disease is an inflammatory bowel disease (IBD) that can cause abdominal pain, diarrhea, fever, and weight loss. Infusion for Crohn’s disease can help mitigate these symptoms.

Skyrizi IV is an IV infusion medication used to treat adult patients with active Crohn’s disease.
Cimzia is an injectable medication approved for the treatment of adult patients with moderate to severe active Crohn's disease.
Remicade is an IV infusion medication approved for the treatment of adults and pediatric patients aged 6 years and older with moderately to severely active Crohn’s disease.
Entyvio is an IV infusion therapy used to treat adult patients with active moderate to severe ulcerative colitis or Crohn's disease.
Avsola is a biosimilar agent to Remicade, indicated as maintenance therapy in adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, loss of response, or intolerance to immunomodulators or corticosteroids.
Inflectra is a biosimilar agent to Remicade, approved for the treatment of adults with moderately to severely active Crohn’s disease.
Stelara SQ and Stelara IV are both biologics indicated for the treatment of adult patients with moderately to severely active Crohn’s Disease.
Renflexis is an intravenous formulation indicated for the induction and maintenance of clinical remission in adult and pediatric patients 6 years of age and older with moderate to severe Crohn's Disease whose disease has not responded adequately to conventional therapy.

Ulcerative Colitis

Ulcerative colitis is another type of IBD that causes inflammation in the digestive tract and leads to stomach cramps, bloody stools, and fatigue.

Skyrizi IV is an IV infusion therapy approved for the treatment of adult patients with moderate to severe active ulcerative colitis.
Remicade is an IV infusion medication approved for the treatment of adults and pediatric patients aged 6 years and older with moderately to severely active ulcerative colitis.
Entyvio is an IV infusion therapy used to treat adult patients with active moderate to severe ulcerative colitis or Crohn’s disease.
Avsola is a biologic agent indicated as maintenance therapy in adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, loss of response, or intolerance to immunomodulators or corticosteroids.
Inflectra is a biosimilar agent approved for the treatment of adults with moderately to severely active ulcerative colitis and psoriatic arthritis.
Stelara SQ and Stelara IV are both biologics indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.
Renflexis is an intravenous formulation indicated for the induction and maintenance of clinical remission in adult and pediatric patients 6 years of age and older with moderate to severe ulcerative colitis whose disease has not responded adequately to conventional therapy.
Tremfya is an IV infusion therapy approved for the treatment of adult patients with moderate to severe active ulcerative colitis.

Infusion therapy is a safe and effective treatment option for those with gastrointestinal disorders. By bypassing other body systems, infusion therapy can provide relief from symptoms, including nausea and abdominal pain. It also helps reduce inflammation in the body, which makes it an effective treatment for inflammatory bowel disease and other digestive disorders. Additionally, infusion therapy can provide increased nutrient levels to help with digestion and overall health.

Frequently Asked Questions

Do I need a doctor's order to receive IV treatment for gastrointestinal conditions?

Yes, to receive infusion therapy, you will need an order from your primary care doctor or specialist. If you’d like to get started with Smart Infusion but don’t yet have an order from your doctor, contact our team. We’ll help you and your existing care team coordinate an order to ensure that you can start receiving the infusion therapy needed for your condition.

Do you offer private rooms for GI infusion therapy?

Yes, we have private rooms available for infusion therapy treatments. These rooms provide a comfortable and relaxing environment for you to receive your treatment in privacy.

Can you use my existing IV port for my therapy?

Yes, depending on the type of therapy you are receiving and the condition of your existing IV port, it may be possible to use your existing IV port during your infusion therapy. Check with your doctor or healthcare provider to understand if this is an option for you.

How can I get started with GI infusion therapy near me?

Smart Infusion makes it simple to get started. Just fill out our simple online form to begin.

Gastroenterology